FIVCX
Price
$34.61
Change
+$0.28 (+0.82%)
Updated
Dec 24 closing price
VMVAX
Price
$84.74
Change
+$0.61 (+0.73%)
Updated
Dec 24 closing price
Ad is loading...

FIVCX vs VMVAX

Header iconFIVCX vs VMVAX Comparison
Open Charts FIVCX vs VMVAXBanner chart's image
Delaware Opportunity C
Price$34.61
Change+$0.28 (+0.82%)
VolumeN/A
CapitalizationN/A
Vanguard Mid-Cap Value Index Admiral
Price$84.74
Change+$0.61 (+0.73%)
VolumeN/A
CapitalizationN/A
FIVCX vs VMVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FIVCX vs. VMVAX commentary
Dec 25, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FIVCX is a Buy and VMVAX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VMVAX pays higher dividends than FIVCX: VMVAX (2.14) vs FIVCX (0.29). FIVCX was incepted earlier than VMVAX: FIVCX (2 years) vs VMVAX (13 years). VMVAX is a more actively managed with annual turnover of: 22.00 vs. FIVCX (11.00). FIVCX has a lower initial minimum investment than VMVAX: FIVCX (1000) vs VMVAX (3000). VMVAX annual gain was more profitable for investors over the last year : 13.66 vs. FIVCX (3.36).
FIVCXVMVAXFIVCX / VMVAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence2 years13 years-
Gain YTD2.63112.96220%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net AssetsN/A32.8B-
Annual Yield % from dividends0.292.1414%
Returns for 1 year3.3613.6625%
Returns for 3 yearsN/A11.75-
Returns for 5 yearsN/A38.87-
Returns for 10 years157.5483.91188%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYVYX577.6411.23
+1.98%
Rydex NASDAQ-100® 2x Strategy H
DSMLX59.410.60
+1.02%
Touchstone Large Company Growth Instl
IPMIX21.390.06
+0.28%
Voya Index Plus MidCap Port I
BGSIX74.15N/A
N/A
BlackRock Technology Opportunities Instl
GEMJX12.01N/A
N/A
Goldman Sachs Emerging Mkt Eq ex. ChnIns